https://www.ft.com/content/9d84d534-b2dd-4cff-85d1-aee137b26a45
GT Biopharma Announces Issuance Of Two New Patents Covering TriKE Platform Technologies
GT Biopharma, Inc. (the "Company") (NASDAQ:GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager,